Researchers identified genetic-related structural defects that prevent cilia from clearing mucus in primary ciliary dyskinesia patients.
RT’s Three Key Takeaways:
- New Genetic Drivers: Mutations in two previously unlinked genes, ECT2L and DZANK1, cause primary ciliary dyskinesia (PCD) by disrupting critical protein complexes at the base of airway cilia.
- Solving Diagnostic Mysteries: The findings provide biological explanations for patients whose disease previously lacked an identifiable cause, addressing an estimated 20% to 30% of PCD cases that remain genetically unexplained.
- Mechanisms of Airway Dysfunction: Defects in the ciliary transition zone alter the physical structure of cilia and prevent synchronized beating, impairing mucus clearance from the respiratory tract and identifying potential new targets for therapeutic development.
A research team led by investigators at Harvard Medical School (HMS) and University Children’s Hospital Münster in Germany has uncovered structural and genetic defects responsible for primary ciliary dyskinesia (PCD), according to a study published Sept 10 in Science.
PCD is a rare genetic disorder that impairs motile cilia, the microscopic hair-like appendages that beat in synchrony to move fluids and clear mucus, debris, and pathogens from the respiratory tract. When cilia fail to function properly, patients experience chronic respiratory illness, recurrent pulmonary infections, sinus complications, and bronchiectasis. Changes in more than 50 genes have been documented to cause the condition, yet approximately 20% to 30% of cases have remained genetically unexplained, according to the study authors. Existing healthcare therapies can only slow disease progression rather than stop or cure the disorder.
Using advanced imaging and artificial intelligence tools, the research team identified the structure and protein composition of the transition zone, a specialized region located at the base of each cilium. The team demonstrated that mutations in two genes, ECT2L and DZANK1, disrupt the protein complexes that link doublet microtubules together within this transition zone, according to the report.
“This is an example of how combining in situ structural biology with genetics can address fundamental questions and illuminate the causes of human disease,” said Alan Brown, professor of biological chemistry and molecular pharmacology in the Blavatnik Institute at HMS.
Structural Gatekeeper Defects in the Transition Zone
To examine airway cell cultures at the sub-nanometer level, co-first author Haixia Zhou, research fellow in biological chemistry and molecular pharmacology at HMS, applied cryo-electron tomography augmented by cryo-focused ion beam milling (cryo-FIB-ET), according to the study. This technology flash-freezes biological specimens and uses an ion beam to mill sections between 100 and 250 nanometers thick, generating high-resolution three-dimensional reconstructions.
The imaging revealed nine types of proteins within the transition zone, four of which assemble into linker complexes that anchor the doublet microtubules together, the researchers reported. When genetic mutations reduce levels of ECT2L and DZANK1, these linker assemblies break down. The investigators observed that this disruption changes the structural shape of cilia, creating abnormal bulbous tips and impairing their ability to beat coordinatedly to clear mucus.
Because the transition zone acts as a molecular gate controlling the entry and exit of proteins into the ciliary shaft, the authors noted that these mutations likely compromise the selective barrier, allowing improper proteins to enter while excluding necessary structural components.
Clinical and Diagnostic Implications for Respiratory Care
Most individuals with PCD inherit two mutant copies of a causative gene, and the condition is typically diagnosed during childhood, according to the researchers. Beyond respiratory complications, dysfunctional cilia can lead to chronic inner ear infections, fertility challenges, and organ laterality defects in roughly half of diagnosed individuals.
Prior to this investigation, transition zone mutations had only been associated with non-motile ciliopathies, whereas known PCD mutations involved other parts of the ciliary machinery. By establishing a direct mechanistic link between transition zone defects and motile ciliary failure, the authors concluded that these findings provide answers for unresolved patient cases, enhance diagnostic screening panels, and reveal novel protein targets for therapeutic development.
